Susan Marley, senior clinical manager, Novartis
Jenny Martin, manager of clinical operations, GU oncology, University of Washington
Scot Maxon, associate director of medical information, ZymoGenetics
MaryAnne McAdams, director of commercial development, Slate Pharmaceuticals [Added: 6:35 pm, 1/4/11]
Jennifer McCarty, senior manager, research and development informatics, Amgen [Added: 12:25 pm, 1/4/11]
Candice McCoy, principal, Phase Plus Consulting
Teri McCune, clinical research consultant, president, TEMC
Neil McDonnell, deputy director of strategy, global health, Bill & Melinda Gates Foundation
Jeff McGrew, scientific director, Amgen
Peggy McHugh, senior director of clinical operations, IRX Therapeutics
Jim McKibben, retired from Amgen in 2010 [Added: 4:40 pm, 1/4/11]
Karen McLeod, associate director, labeling, ZymoGenetics
Cathy McMahan, director of cell sciences, Trubion Pharmaceuticals (now Emergent Biosolutions)
Kim McNeil, Realtor, Nations Realty [Added: 4:40 pm, 1/4/11]
Cathy McSharry, technical support [Added: 1:15 pm, 1/14/11]
Gary Means, principal scientist, Amgen
Jennifer Mitcham, director of program management, Theraclone Sciences
Thomas Mizelle, biotechnology executive
Ken Mohler, senior vice president of R&D, chief scientific officer, Trubion Pharmaceuticals (now Emergent Biosolutions)
Laura Morgan, associate director, QA, Acucela
Philip Morissey, vice president of biology, Amnis
Jurgen Mullberg, group head and project leader in antibody discovery [Added: 9:20 pm, 1/4/11]
Eileen Murphy, senior program manager, Seattle Biomedical Research Institute [Added: 12:40 pm, 1/6/11]
Suzanne Nelson, senior QA associate, Dendreon
Terry Newcomb, senior director, clinical research, Gilead Sciences
Jennifer Newman, associate director of operations and planning, preclinical R&D, ZymoGenetics
Leslie Nordstrom, QC analyst, BioLife Solutions
Anne Norment, owner, Vista Biotechnology Analysis
Barbara Norwood, quality control supervisor, in vitro biology and microbiology, Dendreon [Added: 8:05 pm, 1/17/11]
Carol Olson, co-chair, Sustainable Path Foundation
Robert Overell, president and CEO, PhaseRx
Mimi Ozaki, clinical regulatory assistant, Trubion Pharmaceuticals (now Emergent Biosolutions)
Cyndi Paluch, reimbursement regional manager, Bayer Healthcare
Dawn Papp, senior executive assistant, Dendreon [Added: 8:05 pm, 1/12/11]
Linda Park, co-chair, Sustainable Path Foundation
Vickie Park, project coordinator, Northwest Hospital
